Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: loteprednol etabonate; tobramycin

Summary for Generic Name: loteprednol etabonate; tobramycin

Drug Master File Entries: see list9
Suppliers: see list1

Pharmacology for Ingredient: loteprednol etabonate; tobramycin

Clinical Trials for: loteprednol etabonate; tobramycin

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis
Status: Completed Condition: Conjunctivitis

A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin
Status: Completed Condition: Ocular Hypertension

Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
Status: Completed Condition: Conjunctivitis; Keratitis; Blepharitis

Pediatric Zylet Safety and Efficacy Study
Status: Completed Condition: Chalazion; Hordeolum

Zylet vs TobraDex in Blepharokeratoconjunctivitis
Status: Completed Condition: Blepharokeratoconjunctivitis

Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis
Status: Active, not recruiting Condition: Meibomian Gland Dysfunction; Posterior Blepharitis

Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus Tobradex
Status: Completed Condition: Inflammation

Intraocular Pressure With Loteprednol and Dexamethasone
Status: Completed Condition: Glaucoma, Open-Angle; Ocular Hypertension

Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
Status: Completed Condition: Healthy

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bausch And Lomb
loteprednol etabonate; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050804Dec 14, 2004RXYes5,540,930*PED<disabled>Y
Bausch And Lomb
loteprednol etabonate; tobramycin
SUSPENSION/DROPS;OPHTHALMIC050804Dec 14, 2004RXYes5,747,061*PED<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology